CVRx, Inc.

NasdaqGS:CVRX

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

🏥 Hospitals & Clinics

🩺 Medical Instruments

💻 Telehealth

Location

United States

Market Cap

USD 152.79 M

Share Price

USD 5.86

Avg Daily Volume

421,031

Change (1 day)

0.52%

Change (1 year)

-47.26%

Change (YTD)

-53.75%

CVRx, Inc. Share Price on June 20, 2025: USD 5.86

CVRx, Inc. Share Price is USD 5.86 on June 20, 2025, a -47.26% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

CVRx, Inc. 52-week low Share Price is USD 18.40 on June 20, 2025, which is 213.99% above the current Share Price.
CVRx, Inc. 52-week low Share Price is USD 4.75 on June 20, 2025, which is -18.94% below the current Share Price.
CVRx, Inc. average Share Price for the last 52 weeks is USD 10.71.

Daily

From:

To:

Zoom:

Key data

Date	Share Price	Share Price	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)

NasdaqGS: CVRX

CVRx, Inc.

CEO	Mr. Kevin Hykes
IPO Date	June 30, 2021
Location	United States
Headquarters	9201 West Broadway Avenue
Employees	206
Sector	🏥 Health Care
Industries Clinical Trials 🧬 Biotechnology 🏥 Hospitals & Clinics 🩺 Medical Instruments 💻 Telehealth

Description

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.